• /SiteCollectionImages/Flaggen/be.png
  • /SiteCollectionImages/Flaggen/cn.png
  • /SiteCollectionImages/Flaggen/dk.png
  • /SiteCollectionImages/Flaggen/de.png
  • /SiteCollectionImages/Flaggen/fi.png
  • /SiteCollectionImages/Flaggen/fr.png
  • /SiteCollectionImages/Flaggen/it.png
  • /SiteCollectionImages/Flaggen/nl.png
  • /SiteCollectionImages/Flaggen/no.png
  • /SiteCollectionImages/Flaggen/at.png
  • /SiteCollectionImages/Flaggen/pl.png
  • /SiteCollectionImages/Flaggen/ru.png
  • /SiteCollectionImages/Flaggen/se.png
  • /SiteCollectionImages/Flaggen/ch.png
  • /SiteCollectionImages/Flaggen/es.png
  • /SiteCollectionImages/Flaggen/cz.png
  • /SiteCollectionImages/Flaggen/ua.png
  • /SiteCollectionImages/Flaggen/hu.png
  • /SiteCollectionImages/Flaggen/uk.png

BWT closes takeover of CHRIST pharma & biotech business

1.10.2009 6:00   Mondsee

BWT closes the takeover of the pharmaceutical water activities of the Christ Water Technology Group incl. a 49% stake in Zeta Group as planned. Effective today, the staff of BWT is expanding by 200 highly-qualified, experienced employees who under the brand “Christ Aqua Pharma & Biotech” and in a new organisation managed by Mr. Henrik Forslund, offer complete solutions for pure- and ultra-pure water, water for injection purposes, sterile steam, cleaning systems (CIP/SIP), pharmaceutical waste water treatment and a comprehensive range of services. At the same time, BWT is extending its presence with the customer-focused sites in Switzerland, Germany, Sweden and Ireland, as well as the locations in China and India. Additionally, the 49% Zeta participation offers an interesting future potential in the biopharma business.

 
Contact information:
Andreas Weißenbacher, Chairman of the Board

Phone: +43 (0)6232 5011 1111

Gerhard Speigner, Finance Director
Phone: +43 (0)6232 5011 1112

Josef Nußdorfer, CEFA, Investor Relations & Corporate Communications
Phone: +43 (0)6232 5011 1113, Fax +43 (0)6232 5011 1109,
E-Mail: Josef.Nussdorfer@bwt-group.com
BWT-AG, A-5310 Mondsee, Walter-Simmer-Str. 4

Financial calendar:

Report 3rd quarter 2009: 13 November 2009